About Crescita Therapeutics (TSE:CTX)
Crescita Therapeutics Inc., a dermatology company, provides over-the-counter and prescription products for the treatment and care of skin diseases and their symptoms. It owns various proprietary drug delivery platforms, including DuraPeel and MMPE that support the development of patented formulations, which facilitate the delivery of active drugs into or through the skin. The company's prescription products include Pliaglis, a topical local anaesthetic cream that provides dermal analgesia on intact skin prior to superficial dermatological procedures; Mical 1 that is in Phase II stage for the treatment of psoriasis; and Mical 2, which is in preclinical stage for the dermatological skin treatment. Its non-prescription skincare products comprise skincare products for aging, acne, rosacea, pigmentation, dehydration, and sensitivity under the Laboratoire Dr Renaud brand; a line of cosmeceutical products for anti-aging medical procedures under the Pro-Derm brand; anti-aging skincare products to 35 years of age and over consumers under the Premiology brand; and a range of dermatology solutions under the ISDIN brand. The company also offers contract manufacturing services. It operates in Canada, Europe, the United States, and internationally. Crescita Therapeutics Inc. was incorporated in 2016 and is headquartered in Mississauga, Canada.
Industry, Sector and Symbol
Trailing P/E Ratio-0.927536231884058
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
Return on Equity-8.39%
Return on Assets-5.49%
Crescita Therapeutics (TSE:CTX) Frequently Asked Questions
What is Crescita Therapeutics' stock symbol?
Crescita Therapeutics trades on the Toronto Stock Exchange (TSX) under the ticker symbol "CTX."
Who are some of Crescita Therapeutics' key competitors?
Some companies that are related to Crescita Therapeutics include New Millennium Iron (NML), Eagle Energy (EGL), Cequence Energy (CQE), Karnalyte Resources (KRN), Bri-Chem (BRY), Zargon Oil and Gas (ZAR), DragonWave (DRWI), Niko Resources (NKO), Spyglass Resources (SGL), Itafos (MBC), Southern Pacific Resource (STP), Labrador Iron Mines (LIM), Invesque (HLP.U), 2242749 Ontario (ARF), Aastra Technologies (AAH), Agrium (AGU), Amica Mature Lifestyles (ACC) and Argent Energy Trust (AET.UN).
How do I buy Crescita Therapeutics stock?
Shares of Crescita Therapeutics and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.
What is Crescita Therapeutics' stock price today?
One share of Crescita Therapeutics stock can currently be purchased for approximately C$0.73.
How big of a company is Crescita Therapeutics?
Crescita Therapeutics has a market capitalization of C$9.10 million.
How can I contact Crescita Therapeutics?
Crescita Therapeutics' mailing address is 7560 Airport Rd Unit 10, MISSISSAUGA, ON L4T 4H4, Canada. The company can be reached via phone at +1-905-6734295.
MarketBeat Community Rating for Crescita Therapeutics (CTX)MarketBeat's community ratings are surveys of what our community members think about Crescita Therapeutics and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Crescita Therapeutics (TSE:CTX) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
Earnings History for Crescita Therapeutics (TSE:CTX)
No earnings announcements for this company have been tracked by MarketBeat.com
Crescita Therapeutics (TSE:CTX) Earnings Estimates
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for Crescita Therapeutics (TSE:CTX)
No dividend announcements for this company have been tracked by MarketBeat.com
Crescita Therapeutics (TSE CTX) Insider Trading and Institutional Ownership History
Crescita Therapeutics (TSE CTX) Insider Trades by Quarter
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
|9/8/2017||Anthony Edward Dobranowski||Director||Buy||5,000||C$0.61||C$3,050.00|
Crescita Therapeutics (TSE CTX) News Headlines
Crescita Therapeutics (TSE:CTX) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Financials are not available for this stock.
Crescita Therapeutics (TSE CTX) Stock Chart for Wednesday, February, 21, 2018